Dai-Ichi Karkaria growth ratios

Per cent unless marked ×
Tap a line for its trendFY25Mar 2025FY24Mar 2024FY23Mar 2023FY21 and earlierAlpha Plus
+37.8%−28.5%+51.0%
FY21 and earlierEvery year the company has filed comes with Alpha Plus.
+129.9%−60.4%+181.3%
+246.6%−134.8%+132.0%
−61.3%−13.5%+211.4%
+3.6%−10.2%+16.3%
+2.9%+8.7%+14.3%
+112.9%——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

DAICHI₹303.00

Dai-Ichi Karkaria Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXELANTASGRAUWEILINDOKEMJYOTIRESKANCHI
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
Revenue Growth—+51.0-28.5+37.8
EBITDA Growth—+181.3-60.4+129.9
EBIT Growth—+132.0-134.8+246.6
Net Income Growth—+211.4-13.5-61.3
Total Assets Growth—+16.3-10.2+3.6
Total Equity Growth—+14.3+8.7+2.9
Cash from Operations Growth———+112.9
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.